Calvin Scott Recalls Thyroid 1 Grain Tablets Due to Packaging Defects
Calvin Scott & Co. is recalling specific lots of Thyroid 1 Grain Tablets because light-sensitive products were repackaged in transparent pouches, violating CGMP standards.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a CGMP deviation regarding packaging that could compromise drug stability, fitting the criteria for moderate severity without reported injuries.
Plain-English summary
Calvin Scott & Company, Inc. is recalling Thyroid 1 Grain Tablets, 28-count bags, due to Current Good Manufacturing Practice (CGMP) deviations. The affected product is distributed by Calvin Scott & Co., Inc. in Albuquerque, NM, and manufactured by RLC Labs in Cave Creek, AZ. The specific NDC is 64727-3300-02.
The recall was initiated because light-sensitive drug products were repackaged in transparent or partially transparent pouches. This packaging choice deviates from CGMP requirements for protecting light-sensitive medications. The affected lots include Lot #19233 (Exp. 08/20), Lot #19254 (Exp. 09/20), and Lot #19273 (Exp. 1/21). The product was distributed nationwide within the United States.
Consumers should check their medication for the specific lot numbers and expiration dates listed above. If you possess the recalled product, you should stop using it and contact your pharmacist or the recalling firm for instructions on return or disposal.
The recalled product
- Product
- Thyroid 1 Grain Tablets, 28-count bags, Distributed by: Calvin Scott & Co., Inc. Albuquerque, NM 87123, Manufactured by RLC Labs, Cave Creek, AZ 85331, NDC 64727-3300-02
- Manufacturer
- Calvin Scott & Company, Inc.
- Category
- Drug — Prescription Medication
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot #: 19233
- Exp. Date: 08/20
- 19254
- Exp. Date 09/20
- 19273
- Exp. Date: 1/21
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 19 recalled by Calvin Scott & Company, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 19 products in this recall →Related recalls
Same manufacturer · Calvin Scott & Company, Inc.
See all →- ModerateBenzphetamine tablets recalled due to label mix-up with Benzonatate
FDA (Drugs) · 2022-06-01
- SevereBenzonatate 100mg Capsules Label Mix-up — Wrong Medication in Bottles
FDA (Drugs) · 2022-06-01
- ModerateCalvin Scott Recalls Diethylpropion Tablets Due to Stability Deviations
FDA (Drugs) · 2020-10-14
- ModerateCalvin Scott Recalls Diethylpropion Tablets Due to Missing Stability Studies
FDA (Drugs) · 2020-10-14
- ModerateCalvin Scott Recalls Phentermine Capsules Due to Stability Study Deviations
FDA (Drugs) · 2020-10-14
Same hazard · packaging defect
See all →- HighMD Wipe Outz Numbing Tattoo Wipes Recalled for Child Poisoning Risk
CPSC · 2026-08-27
- SevereDermalon Sutures Recalled for Potential Sterile Barrier Packaging Defects
FDA (Devices) · 2026-08-19
- HighV-Loc 90 Absorbable Wound Closure Devices Recalled for Packaging Defects
FDA (Devices) · 2026-08-19
- HighV-Loc 180 Absorbable Wound Closure Device Recalled for Packaging Defects
FDA (Devices) · 2026-08-19
- HighBiopsy Forceps Recall: Sterile Packaging Breach Risk
FDA (Devices) · 2026-08-12